Can Keros Therapeutics (KROS)’s $20M Takeda Pharmaceutical Company Limited (TAK) Milestone Unlock a Billion-Dollar Opportunity? — See source for full details.
$TAK
Price history, market instrument context, member research, and related headlines in one place.
TAK key statistics
NYSEUSD
52-week range
$12.9998%$20.39
Latest session $20.17–$20.32Takeda Pharmaceutical Company Limited (TAK) is a stock instrument quoted on NYSE in USD. The most recently published price is $20.24, down $0.12 (0.59%) from the previous close of $20.36. It has traded between $20.17 and $20.32 in the latest session. Over the past year it has ranged from $12.99 to $20.39, leaving it trading at the top of its 52-week range. Reported volume for the session was 2.1M. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
WOOK AIASK ANYTHING · NEVER ADVISES
Meet Wook AI, your friendly assistant. Ask how something works, about any company, fund or coin, or have it do the math — live figures come from this site’s own lookups, and you’ll see which ones it used.
Source-linked intelligence
Related news
Takeda Pharmaceutical reports Q1 results — See source for full details.
Loading $TAK research…